A 31-year-old woman without any underlying disease contracted severe invasive Haemophilus influenzae type b (Hib) infection but developed no antibodies to the Hib capsular polysaccharide. Serum immunoglobulin levels were normal, but she had an isolated deficiency of antibody to Hib. Subsequently, immunization with a tetanus toxoid -conjugated Hib vaccine induced only a minimal response. However, she had a protective level of antibody (ú1 mg/mL) after the fifth vaccination.
Invasive Haemophilus influenzae type b (Hib) infections oc-lymphocyte subsets; and response to mitogen activation. HIV serology was negative, but she had IgG antibodies to several cur almost exclusively in young children and are rarely seen other viruses. in adults [1] . Protective antibodies to the Hib capsular polysac-
The levels of all IgG antibodies to Hib CP were studied by charide (CP) are normally acquired during childhood and thereusing a previously described avidin-biotin -based ELISA [4] after prevent invasive Hib disease [2] . The low immunogenicity with some modifications. Briefly, microplates were precoated of bacterial polysaccharides in young children can be overcome with 5 mg of avidin/mL, and after overnight incubation, they by coupling the CP to protein carriers, a technique used in were coated with biotinylated Hib CP (concentration, 2 current conjugated Hib vaccines [3] . Such conjugated Hib vacmg/mL). After blocking of nonspecific binding, serum samples cines were in 1993 (the time of investigation of this case) in serial dilutions were incubated overnight. Mouse antibody included in the Swedish infant vaccination program.
to human IgG conjugated with alkaline phosphatase was added to the plates and incubated; after the reaction with enzyme Case Report substrate (o-nitrophenyl-b-D-galactopyranoside) in 1 M diethanolamine buffer (pH, 9.8) was developed, the plates were read In February 1992, a 31-year-old woman with no history of spectrophotometrically at 405 nm. The reference for the quantiincreased susceptibility to infections contracted an acute high fication of antibody levels used was isolated human IgG to Hib fever (temperature, 40ЊC), myalgia, throat pain, and difficulty CP (U.S. Food and Drug Administration, Bethesda, MD). We in swallowing. Two children in the same household (6 months considered the concentration ú1 mg/mL as a protective level and 1.5 years of age, respectively) were also ill with noncompliof antibody to Hib CP since such a level achieved after vaccinacated upper respiratory tract infections. On the third day of tion clearly confers long-lasting protection against invasive Hib illness, she had increasing malaise, shivering, and persistent disease even in infants [5] . We found only very low (nonprotechigh fever and was admitted to the hospital. At the time of tive) amounts of specific antibody to Hib CP (0.05 mg/mL) in admission, localized supraglottic swelling, but no classic epithis patient by ELISA. glottitis, was observed. Treatment with cefuroxime (1.5 g t.i.d.)
In April 1994, immunization with a conjugated vaccine was given, and blood cultures later yielded b-lactamase-(0.5 mL subcutaneously; Act-HIB, Pasteur-Mérieux MSD, producing Hib. After 1 day of intensive care, her condition Lyon, France) was started; however, in contrast to the one dose rapidly improved, and a CT on the fifth day showed that moderthat is usually sufficient for normal adults, multiple doses given ate parapharyngeal edema remained. After 1 week, she was at 0, 2, 4, 8, and 15 months were required. The antibody redischarged.
sponse developed very slowly (figure 1), and protective levels Laboratory studies revealed the following normal values: of antibodies to Hib CP (ú1 mg/mL) were reached only after WBC counts; levels of serum IgG, IgM, IgA, and IgG subfive vaccinations (3.1 mg/mL). The prevaccination level of anticlasses; C3, C4, and factor B levels; T lymphocyte profile; body to Hib CP in our patient's healthy sister (who was 2 years younger) was 0.16 mg/mL, but the sister had a good response after a single dose of Act-HIB (10.4 mg/mL). bodies to Hib CP showed that both the patient and her sister to C polysaccharide both before vaccination with Pneumovacc N and more abundantly with numerous clones after vaccination. responded to vaccination with two different IgG2 clones ( figure  1A) . Our patient developed the visible clones only after the While we did not quantify the antibody levels, the isoelectric focusing and affinity immunoblotting patterns clearly showed third dose of vaccine, while her sister responded to the first dose with one IgG2 clone (shown by more strongly stained the development of the antibody response to these polysaccharides. bands in figure 1A ) and one IgG1 clone. No IgG1 clones developed in our patient after all vaccinations.
The antibody response to the carrier protein (tetanus toxoid) was quantified after each vaccination. Both sisters showed pro-A few weakly stained bands of IgG2 antibodies to E. coli K100 CP were detected in all serum samples, which did not tective levels of antibody to tetanus toxoid before Act-HIB vaccination. However, these levels rose significantly after the change during the course of vaccination and did not correspond to the bands of antibodies to Hib CP. We conclude that no first dose of vaccine and thereafter remained at a constant high level (data not shown in figure 1 ), thus indicating an unimpaired cross-reaction between E. coli K100 CP and antibodies to Hib was found in either sister's serum.
response to this protein antigen. Clones of IgG1 and IgG2 antibodies to outer membrane proteins of H. influenzae were A well-defined clone of IgG antibody expressing Id-1 was found in our patient before the first vaccination. It did not found in both sisters as well. change after all the vaccine doses were administered ( figure  1B) . A few weakly stained bands of IgG antibody expressing Discussion Id-1 and two abundantly developing clones were detected in the sister's serum before and after vaccination, respectively Invasive Hib infections are very uncommon in adults without predisposing underlying disease. An annual incidence of 0.22 ( figure 1B) . While the pattern of serum samples from the sister showed the expression of Id-1 by antibodies to Hib CP, the case per 100,000 population has been reported [1] . Protective antibodies to Hib CP may develop during childhood because antibodies expressing Id-1 in our patient's serum were not related to antibodies to Hib CP ( figure 1C) .
of natural exposure to cross-reacting antigens like E. coli K100 CP [2] . In one study [8] , after invasive Hib infection, high We estimated the response of our patient to other polysaccharide vaccines (Pneumovacc N and Meningovacc A/C, Pasteur-levels of antibody to Hib CP were induced in most adults, findings in clear contrast to the low amounts of antibodies Merieux MSD) by using the combination of isoelectric focusing and affinity immunoblotting. IgG1 and IgG2 antibodies to me-found in our patient. The conjugated Hib vaccines were developed primarily for ningococcal CPs A and C appeared as very weakly stained bands before vaccination but developed into intensely stained infants but also are very efficient for vaccinating healthy nonimmune adults [3] . Even in immunocompromised persons, e.g., clones of IgG2 antibodies to both CP A and CP C after vaccination.
patients without spleens or bone marrow recipients, these vaccines are good immunogens [9, 10] . In our patient, however, Antibodies to pneumococcus were studied in samples preabsorbed with C polysaccharide. The results showed the presence the conjugated Hib vaccine did not generate protective amounts of antibodies to Hib CP immediately. Repeated immunizations of clones of IgG1 and IgG2 antibodies to CP 6B, which became more intensively stained after vaccination. No antibody to CP were required before the patient, in contrast to her sister, slowly responded. 14 was found before immunization, but after immunization, numerous clones of IgG2, but none of IgG1, antibody appeared.
We can conclude that this was a case of a selective deficiency of antibody to Hib CP that could be overcome by repeated At the same time, we noticed the presence of IgG2 antibodies / 9c3d$$oc11 09-18-97 21:41:56 cida UC: CID
